
    
      To confirm the safety and performance of the Medtronic Engagerâ„¢ Transcatheter Aortic Valve
      Implantation System via direct aortic approach in patients with symptomatic severe aortic
      valve stenosis at high or extreme risk for surgical aortic valve replacement for which
      treatment via direct aortic access is preferred.
    
  